# Assessment of tDCS-Induced Neuronal Responses in Multiple Sclerosis (MS) With Advanced MRI

> **NCT03564496** · NA · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 73 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DEVICE:** tDCS Administration during MRI
- **DEVICE:** Remotely-supervised Daily tDCS Administration
- **DEVICE:** Optional 15 minutes of imaging + simultaneous tDCS up to 4.0mA

## Key facts

- **NCT ID:** NCT03564496
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-09
- **Primary completion:** 2021-09-29
- **Final completion:** 2021-09-29
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2024-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03564496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03564496, "Assessment of tDCS-Induced Neuronal Responses in Multiple Sclerosis (MS) With Advanced MRI". Retrieved via AI Analytics 2026-09-05 from https://api.ai-analytics.org/clinical/NCT03564496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*